Synameta Therapeutics SARL

Enabling breakthrough medicines achieve the outcomes they were designed for.

We unlock the full therapeutic potential of innovative drug candidates through our next-generation nanomedicine delivery platform. We transform today’s innovations into tomorrow’s cures by de-risking clinical programs and amplifying therapeutic impact for patients. We want to establish our biovectors as the universal standard for targeted therapeutic delivery.

Less than 1% of cancer therapies reach intratumoral targets: we are fixing that!